116:109741 Thymosin beta-4 and peptide-mediated cellular signaling pathways Dou Y, Lee A, Zhu L, Morton J, Ladiges W., Aging Pathobiology and Therapeutics , 2020
By partnering with the company, businesses can expand their product portfolio with a trusted antioxidant therapy while contributing to better healthcare outcomes.
For patients who have exhausted conventional sleep interventions (sleep hygiene, CBT-I, conventional medications) and remain symptomatic, DSIP represents a speculative option with a plausible mechanism
TABA supports SBIR/STTR technology commercialization by helping small businesses make better technical decisions, solve problems, reduce risk, develop and commercialize new product and screen for potential foreign involvement in technology development
FIONA WILLAN: Casey Wesche turned to the injectables when she wanted to lose weight